U.S. stock futures were lower this morning, with the Dow futures falling over 50 points on Thursday.
Shares of Delta Air Lines, Inc. DAL fell sharply in today's pre-market trading after the company posted downbeat second-quarter earnings and issued lower-than-expected third-quarter earnings outlook.
Delta Air Lines reported quarterly earnings of $2.36 per share which missed the analyst consensus estimate of $2.37 per share. The company reported quarterly sales of $16.658 billion which beat the analyst consensus estimate of $15.452 billion, according to data from Benzinga Pro.
Delta Air Lines shares fell 9% to $42.65 in the pre-market trading session.
Here are some big stocks recording losses in today's pre-market trading session.
- Newegg Commerce Inc NEGG shares dipped 9.1% to $1.00 in pre-market trading after declining 5% on Wednesday. Newegg Commerce, on Monday, announced that the presale for its tenth annual FantasTech Sales event is now live.
- Sage Therapeutics, Inc. SAGE declined 7.1% to $10.25 in pre-market trading after declining around 4% on Wednesday.
- LiveWire Group, Inc. LVWR shares fell 6.8% to $7.00 in pre-market trading. LiveWire Group is expected to release its second quarter financial results before the opening bell Thursday, July 25.
- Uxin Limited UXIN fell 5.5% to $1.72 in pre-market trading. Uxin recently announced a partnership with Zhengzhou Airport Industry for the launch of a new used car superstore.
- ZIM Integrated Shipping Services Ltd. ZIM shares declined 5.1% to $18.81 in pre-market trading.
- United Airlines Holdings, Inc. UAL fell 4.8% to $44.85 in pre-market trading in sympathy with Delta, which fell after reporting mixed quarterly earnings.
- American Airlines Group Inc. AAL declined 4.1% to $10.69 in pre-market trading in sympathy with Delta, which fell after reporting mixed quarterly earnings.
- BW LPG Limited BWLP shares slipped 4% to $17.43 in pre-market trading.
- Evotec SE EVO fell 3.7% to $5.02 in pre-market trading. On Wednesday, Evotec and Pfizer disclosed a multi-year collaboration for early drug discovery.
- Conagra Brands, Inc. CAG declined 3% to $27.97 in pre-market trading after the company reported worse-than-expected fourth-quarter sales results and issued FY25 adjusted EPS guidance below estimates.
Now Read This:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.